CAS: 770-31-0; 4-Amino-2-(Methylthio)Pyrimidine-5-Carbaldehyde

该化合物是一种多用途的火利因衍生物,其特点是反应性甲酰胺和氨基功能组,以及甲基硫基替代成分.该化合物是有机合成中的宝贵中间体,特别是在制作三环化合物和药用脚架方面.其结构特征使得化学改变多种多样,有利于在药用化学和农用化学研究中构建复杂的分子.电子施食(氨基)和电吸附(甲酰二丁)组的存在增强了其在凝聚和核循环添加反应中的再活动.该甲基氟酸混合物进一步有助于其在含硫化合物合成中的用途.该产品通常在受控制的条件下处理,因为其敏感性.

结构式图片

相似化合物

863028-98-2 1341335-92-9 937601-32-6

欧盟法规

C&L通报

上下游产品

(4-amino-2-(methylthio)pyrimidin-5-yl)methanol acetic acid 4-chloro-2-methanesulfanylpyrimidine-5-carboxylic acid ethyl ester ethyl 4-amino-2-methylmercaptopyrimidine-5-carboxylate 6-(3,5-dimethoxyphenyl)-2-(methylsulfanyl)pyrido[2,3-d]pyrimidin-7-amine 6-(2-bromo-phenyl)-2-methylsulfanyl-pyrido[2,3-d]pyrimidine-7-carboxylic acid 6-(2,6-dichlorophenyl)-2-methylsulfanyl-8H-pyrido[2,3-d]pyrimidin-7-one

合成工艺路线路线简述

    4-氨基-2-(甲基硫代)嘧啶-5-腈置于二异丁基氢化铝,盐酸体系中,用 四氢呋喃,二氯甲烷,水 作为反应溶剂,化学反应 2.5H,以53.1%的收率获得产物4-氨基-2-甲巯基嘧啶-5-甲醛
    参考文献: Compounds And Compositions As Protein Kinase Inhibitors[fr] Composes Et Compositions Convenant Comme Inhibiteurs De Proteine-Kinases
    标题: Compounds And Compositions As Protein Kinase Inhibitors[fr] Composes Et Compositions Convenant Comme Inhibiteurs De Proteine-Kinases

    海关参考信息

    专利信息


    专利号:US-8188113-B2
    优先权日:2006-09-14
    标 题 :Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
    发明人:FLYNN DANIEL L; PETILLO PETER A; KAUFMAN MICHAEL D; PATT WILLIAM C
    权利人:FLYNN DANIEL L; PETILLO PETER A; KAUFMAN MICHAEL D; PATT WILLIAM C; DECIPHERA PHARMACEUTICALS INC
    摘要:The present invention relates to novel dihydropyridopyrimidinyl, dihydronaphthyridinyl, and related compounds which are kinase inhibitors and modulator useful for the treatment of various diseases. More particularly, the invention is concerned with such compounds, kinase/compound adducts, methods of treating diseases, and methods of synthesis of the compounds. Preferably, the compounds are useful for the modulation of kinase activity of Raf kinases and disease polymorphs thereof. Compounds of the present invention find utility in the treatment of mammalian cancers and especially human cancers including but not limited to malignant melanoma, colorectal cancer, ovarian cancer, papillary thyroid carcinoma, non small cell lung cancer, and mesothelioma. Compounds of the present invention also find utility in the treatment of rheumatoid arthritis and retinopathies including diabetic retinal neuropathy and macular degeneration.

    专利号:US-7196090-B2
    优先权日:2002-07-25
    标题 :Kinase inhibitors
    发明人:CONNOLLY CLEO J CHIVIKAS; DEUR CHRISTOPHER JAMES; HAMBY JAMES MARINO; HOYER DENTON WADE; LIMBERAKIS CHRIS; REED JESSICA ELIZABETH; SCHROEDER MEL CONRAD; TAYLOR CLARKE
    权利人:WARNER LAMBERT CO
    摘要:This invention provides phenyl-substituted pyrimidopyrimidines, dihydropyrimido-pyrimidines, pyridopyrimidines, naphthyridines, and pyridopyrazines of the general formula: n nthat inhibit cyclin-dependent kinase and tyrosine kinase enzymes, methods and intermediate compounds for their synthesis, as well as pharmaceutical compositions and methods for their use in treating, inhibiting or preventing maladies associated with cell proliferative disorders, including angiogenesis, atherosclerosis, restenosis, and cancer.

    专利号:IL-180256-A
    优先权日:2004-07-15
    标题 :Pyrido [d – 2,3] pyrimidinyl-amine history, intermediates for synthesis, process for preparation of compounds, drug, pharmaceutical preparation, and use of history for drug preparation
    成都塞恩斯医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.syns.org
    电话: 028-82093588 18980782991👤
    📞成都塞恩斯医药科技有限公司 ⚠️参考联系方式

    销售电话:028-82093588 18980782991
    邮箱:sales@syns.org
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    参考DOI号:10.1021/jm000271k
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知